PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 35 filers reported holding PSYCHEMEDICS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $217,000 | -25.7% | 11,550 | -24.0% | 0.00% | -33.3% |
| Q2 2018 | $292,000 | -15.1% | 15,200 | -5.6% | 0.00% | 0.0% |
| Q1 2018 | $344,000 | +3.9% | 16,100 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $331,000 | +24.0% | 16,100 | +11.0% | 0.00% | 0.0% |
| Q3 2017 | $267,000 | -24.8% | 14,501 | +2.0% | 0.00% | -25.0% |
| Q2 2017 | $355,000 | +42.0% | 14,218 | +14.2% | 0.00% | +33.3% |
| Q1 2017 | $250,000 | -21.6% | 12,451 | -3.6% | 0.00% | -40.0% |
| Q4 2016 | $319,000 | +15.2% | 12,918 | -7.4% | 0.01% | 0.0% |
| Q3 2016 | $277,000 | -52.2% | 13,951 | -66.9% | 0.01% | -58.3% |
| Q2 2016 | $580,000 | +90.8% | 42,202 | +91.0% | 0.01% | +50.0% |
| Q1 2016 | $304,000 | +32.8% | 22,101 | -2.2% | 0.01% | +33.3% |
| Q4 2015 | $229,000 | -1.3% | 22,601 | -2.2% | 0.01% | -14.3% |
| Q3 2015 | $232,000 | -99.9% | 23,101 | +6.9% | 0.01% | 0.0% |
| Q2 2015 | $320,343,000 | +127526.7% | 21,601 | +43.0% | 0.01% | +40.0% |
| Q1 2015 | $251,000 | -99.9% | 15,101 | +3.4% | 0.01% | +25.0% |
| Q4 2014 | $221,205,000 | – | 14,601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 256,359 | $4,725,000 | 4.06% |
| Moors & Cabot, Inc. | 337,060 | $6,218,000 | 0.90% |
| CARL DOMINO INC | 11,236 | $207,000 | 0.25% |
| Gs Investments, Inc. | 15,500 | $285,665,000 | 0.23% |
| Ativo Capital Management LLC | 46,327 | $854,000 | 0.23% |
| North Star Investment Management Corp. | 78,271 | $1,443,000 | 0.18% |
| RBF Capital, LLC | 78,495 | $1,447,000 | 0.18% |
| Uniplan Investment Counsel, Inc. | 191,822 | $3,535,000 | 0.15% |
| QUANTUM CAPITAL MANAGEMENT | 30,669 | $565,000 | 0.13% |
| CRAWFORD INVESTMENT COUNSEL INC | 205,493 | $3,787,000 | 0.12% |